Oracle Financial Services Software
Ltd’s bumper dividend of over Rs.4,000 crore has revived interest in the stock.
Ex-dividend, the company’s shares settled around Rs.3,485 on Wednesday, which
is about 18% higher than the level of Rs.2,950 per share three months ago.
Including the dividend of Rs.485 per share, the three-month return for
shareholders is as much as 35%.
Apart from the surprise dividend payment, which
came after a gap of eight years, Oracle also announced better-than-expected
results for the quarter ended June 2014. Licence signings across the company’s
global operations picked up significantly, resulting in new signings worth $32
million in the April-June quarter, up 82% from a year earlier
In fiscal year
2013-14, new licence fees had fallen by 18%. Revenue and operating profit grew
by 19% and 46%, respectively, last quarter on a year-on-year basis. It must be
noted here that the large cash outgo will result in a significant drop in
interest income. Analysts at Dolat Capital Market Pvt. Ltd said in a note to
clients that other income is estimated to fall by 40% in the next fiscal year
and profit after tax is estimated to be hit by 10%. But the outlook for the
core business looks brighter.
The analysts said in the note, “The strong
licence fees in the June quarter and the dividend announcements are positive,
both from the perspective of revenue growth as well as shareholder returns.
While the stock has rallied and looks fairly valued at 22 times estimated FY16
earnings, we believe the stock still has potential if it delivers another
strong quarter of licence revenues.”
Oracle Financial has traded at fairly high
valuations, given the expectation that the parent company will make an open
offer to buy out minority shareholders. While this cannot be ruled out, the
recent jump in share price will make the acquisition even more expensive.
Prashant Sharma
PGDM-IIIsem
Oracle Financial
Services Software Ltd’s bumper dividend of over Rs.4,000 crore has
revived interest in the stock. Ex-dividend, the company’s shares settled
around Rs.3,485 on Wednesday, which is about 18% higher than the level
of Rs.2,950 per share three months ago.
Including the dividend of Rs.485 per share, the three-month return for
shareholders is as much as 35%. Apart from the surprise dividend
payment, which came after a gap of eight years, Oracle also announced
better-than-expected results for the quarter ended June 2014.
Licence signings across the company’s global operations picked up
significantly, resulting in new signings worth $32 million in the
April-June quarter, up 82% from a year earlier. In fiscal year 2013-14,
new licence fees had fallen by 18%. Revenue and operating profit grew by
19% and 46%, respectively, last quarter on a year-on-year basis.
It must be noted here that the large cash outgo will result in a
significant drop in interest income. Analysts at Dolat Capital Market
Pvt. Ltd said in a note to clients that other income is estimated to
fall by 40% in the next fiscal year and profit after tax is estimated to
be hit by 10%.
But the outlook for the core business looks brighter. The analysts said
in the note, “The strong licence fees in the June quarter and the
dividend announcements are positive, both from the perspective of
revenue growth as well as shareholder returns. While the stock has
rallied and looks fairly valued at 22 times estimated FY16 earnings, we
believe the stock still has potential if it delivers another strong
quarter of licence revenues.”
Oracle Financial has traded at fairly high valuations, given the
expectation that the parent company will make an open offer to buy out
minority shareholders. While this cannot be ruled out, the recent jump
in share price will make the acquisition even more expensive
Read more at: http://www.livemint.com/Money/HEVEAVYFjPzlZZMQqtLVvI/Huge-dividend-pickup-in-licence-fees-buoy-Oracle-stock.html?utm_source=copy
Read more at: http://www.livemint.com/Money/HEVEAVYFjPzlZZMQqtLVvI/Huge-dividend-pickup-in-licence-fees-buoy-Oracle-stock.html?utm_source=copy
No comments:
Post a Comment